No definition available.
Selective deficiency of immunoglobulin G [IgG] subclasses
DOID EFO Endpoint Browser PheWeb
D3_DEF_IGG
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
249 |
4. Check minimum number of eventsNone |
249 |
5. Include endpointsNone |
249 |
6. Filter based on genotype QC (FinnGen only) |
249 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80
- Name in latin
- Deficientia selectiva subclassium immunoglobulini G
Similar endpoints
↥List of similar endpoints to
Selective deficiency of immunoglobulin G [IgG] subclasses
based on the number of shared cases.
Similar with more cases:
- Immunodeficiency with predominantly antibody defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1014 | 665 | 344 |
| Only index persons | 956 | 637 | 319 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 43.56 | 45.95 | 38.66 |
| Only index persons | 44.64 | 46.75 | 40.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 249 | 184 | 65 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | 47.90 | 47.95 | 47.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 222
- Matched controls
- 2219
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
321.5
222
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
81.4
73
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
67.2
61
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
63.7
58
*
J01MA12
ATC
levofloxacin; systemic
11.0
50.9
116
201
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
603.8
50.5
48
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
25.4
50.3
72
41
H02AB06
ATC
prednisolone; systemic
10.6
49.5
186
729
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
48.8
45
*
R03DC03
ATC
montelukast; oral
8.8
41.8
107
211
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
24.5
41.8
60
33
J45.9
ICD-10 Finland
Asthma, unspecified
8.7
41.5
108
218
J01MA14
ATC
moxifloxacin; systemic
13.2
41.4
78
87
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.8
38.5
159
598
J45.1
ICD-10 Finland
Nonallergic asthma
14.6
38.4
68
65
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
16.8
37.5
62
50
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.5
34.9
74
101
J45.0
ICD-10 Finland
Predominantly allergic asthma
10.6
34.7
73
98
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
24.5
33.1
47
24
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
7.0
33.0
98
225
WW200
NOMESCO Finland
Immunization
27.1
32.0
44
20
TPH04
NOMESCO Finland
Cathetrisation of vein
6.5
31.8
102
257
ZX120
NOMESCO Finland
Intravenous
9.5
31.7
71
105
R50.9
ICD-10 Finland
Fever, unspecified
7.6
31.2
83
161
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
29.9
28
*
H02AB07
ATC
prednisone; oral
6.9
27.9
79
164
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.0
27.7
91
229
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
10.7
27.2
55
66
TDM10
NOMESCO Finland
Puncture of maxillary antrum
11.6
26.0
50
54
R03AK06
ATC
salmeterol and fluticasone; inhalant
6.6
24.7
71
147
J01FF01
ATC
clindamycin; systemic
4.8
24.7
109
372
6BA02
NOMESCO Finland
NA
+∞
24.4
23
*
J47
ICD-10 Finland
Bronchiectasis
27.4
24.3
33
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
5.6
23.9
81
206
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.6
23.7
107
370
J01MA02
ATC
ciprofloxacin; systemic
4.4
23.6
131
551
R03BB04
ATC
tiotropium bromide; inhalant
8.9
23.1
52
74
J01FA06
ATC
roxithromycin; oral
4.2
22.6
140
643
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.6
22.4
51
74
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
4.4
21.9
169
934
R03AC02
ATC
salbutamol; inhalant
4.3
21.8
164
885
R03BA02
ATC
budesonide; inhalant
5.0
21.7
83
238
J01FA15
ATC
telithromycin; oral
6.3
21.4
63
132
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
21.2
20
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
4.0
20.9
152
782
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.6
20.8
47
67
R03BA05
ATC
fluticasone; inhalant
4.7
20.7
83
248
R03AC12
ATC
salmeterol; inhalant
14.7
20.2
34
27
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
20.1
19
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
19.4
65
158
J01FA09
ATC
clarithromycin; systemic
3.8
19.4
120
526
XG474
NOMESCO Finland
Exhalation nntrogen oxide
15.5
18.9
31
23
R03AK08
ATC
formoterol and beclometasone; inhalant
13.2
18.7
33
29
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
12.3
18.7
34
32
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.6
18.6
51
96
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
7.9
18.6
44
67
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
18.4
106
432
R03AC13
ATC
formoterol; inhalant
14.2
18.3
31
25
R03AK07
ATC
formoterol and budesonide; inhalant
4.3
18.0
79
252
H02AB04
ATC
methylprednisolone; systemic
4.8
17.8
67
183
Z01.8
ICD-10 Finland
Other specified special examinations
4.1
17.8
84
287
C01CA24
ATC
epinephrine; parenteral
6.4
17.2
48
92
R01AD08
ATC
fluticasone; nasal
3.6
17.2
108
465
J01FA10
ATC
azithromycin; systemic
3.9
16.8
178
1136
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
183.2
16.7
17
*
J45.8
ICD-10 Finland
Mixed asthma
13.2
16.6
29
25
R06.0
ICD-10 Finland
Dyspnoea
3.8
16.4
85
311
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
16.3
92
360
H02AB09
ATC
hydrocortisone; systemic
12.7
16.3
29
26
R03DA04
ATC
theophylline; systemic, rectal
11.1
16.3
31
32
R03BB01
ATC
ipratropium bromide; inhalant
17.4
16.1
25
16
XG410
NOMESCO Finland
Flow-volume spirometry
12.2
16.0
29
27
J32.4
ICD-10 Finland
Chronic pansinusitis
19.0
16.0
24
14
TGC00
NOMESCO Finland
Bronchial lavation
15.3
16.0
26
19
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
15.8
15
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
15.8
15
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.1
15.7
36
52
R01AD05
ATC
budesonide; nasal
5.9
15.4
45
91
TAB00
NOMESCO Finland
Lumbar puncture
8.8
15.3
33
43
A41.9
ICD-10 Finland
Sepsis, unspecified
16.7
15.3
24
16
J01AA02
ATC
doxycycline; systemic
4.6
15.2
198
1429
N03AX12
ATC
gabapentin; oral
4.4
15.1
61
176
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.6
15.0
46
99
C03CA01
ATC
furosemide; systemic
3.9
15.0
71
238
N02AA05
ATC
oxycodone; systemic
5.1
14.8
50
120
M05BA04
ATC
alendronic acid; oral
7.6
14.8
35
53
R01AD09
ATC
mometasone; nasal
3.1
14.7
143
813
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
24.3
14.5
20
9
N03AX16
ATC
pregabalin; oral
3.5
14.5
83
323
J45
ICD-10 Finland
Asthma
5.4
14.2
45
100
XQ800
NOMESCO Finland
Prick test
5.1
14.1
47
111
UJF30
NOMESCO Finland
Ileoscopy through colon
5.1
14.1
47
111
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
16.1
13.9
22
15
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
13.9
58
172
H04.10
ICD-10 Finland
Dry eye syndrome
5.1
13.8
46
108
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
80.2
13.8
15
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
13.7
13
*
R03BA08
ATC
ciclesonide; inhalant
5.5
13.5
41
87
J46
ICD-10 Finland
Status asthmaticus
12.7
13.2
23
20
N06AX21
ATC
duloxetine; oral
4.5
13.0
50
136
Z3231
NOMESCO Finland
Registered nurse
3.2
13.0
87
371
R01AD12
ATC
fluticasone furoate; nasal
3.0
13.0
101
481
R03BA01
ATC
beclometasone; inhalant
4.1
13.0
56
170
J02AC01
ATC
fluconazole; systemic
2.9
13.0
127
699
J01DB01
ATC
cefalexin; oral
4.5
12.8
203
1558
N02AX02
ATC
tramadol; systemic, rectal
2.9
12.6
115
604
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
+∞
12.6
12
*
A02BC05
ATC
esomeprazole; systemic
2.9
12.6
115
606
J05AB11
ATC
valaciclovir; oral
3.9
12.5
56
176
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.2
12.4
30
47
A07AA02
ATC
nystatin; oral
5.4
12.3
38
82
R03AC03
ATC
terbutaline; inhalant
3.8
12.1
57
186
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
12.1
47
129
J01DA01
ATC
[U] cefalexin; systemic
2.9
12.0
161
1058
J20
ICD-10 Finland
Acute bronchitis
4.6
12.0
43
109
N05BA01
ATC
diazepam; systemic, rectal
4.1
12.0
50
147
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.3
11.9
32
58
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.8
11.9
110
577
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
17.7
11.9
18
11
XW000
NOMESCO Finland
Bone marrow biopsy
8.3
11.8
26
35
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.1
11.7
49
144
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
14.7
11.7
19
14
J31.0
ICD-10 Finland
Chronic rhinitis
4.6
11.6
42
107
R01BA52
ATC
pseudoephedrine, combinations; oral
2.8
11.6
100
499
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.5
11.6
62
223
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
11.6
11
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.6
11.3
26
38
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.7
11.2
39
96
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
11.1
76
325
E0000UV
ATC
NA
2.7
11.1
112
609
N05CF01
ATC
zopiclone; oral
2.8
11.0
89
425
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
11.0
83
380
Z2221
NOMESCO Finland
Medical doctor
2.9
10.9
84
387
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.8
10.9
94
464
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
29.7
10.9
14
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.7
10.8
31
61
J32.1
ICD-10 Finland
Chronic frontal sinusitis
63.1
10.7
12
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
10.6
36
86
J01DA06
ATC
[U] cefuroxime; systemic
3.5
10.5
54
188
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
4.0
10.5
44
129
P01AB01
ATC
metronidazole; oral, rectal
2.6
10.5
115
648
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
10.5
10
*
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
10.4
61
235
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.3
10.3
39
104
N03AX11
ATC
topiramate; oral
9.9
10.3
20
22
WZC30
NOMESCO Finland
Teaching
3.6
10.2
49
161
R03DC01
ATC
zafirlukast; oral
15.6
10.2
16
11
Z3226
NOMESCO Finland
Physiotherapist
3.1
10.1
62
245
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.0
9.9
27
50
R53
ICD-10 Finland
Malaise and fatigue
3.1
9.9
61
241
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.2
9.7
17
15
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.7
9.7
80
380
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
9.6
100
542
S01GX01
ATC
cromoglicic acid; ophthalmic
2.8
9.5
70
309
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
104.3
9.5
10
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
104.3
9.5
10
*
3XA02
NOMESCO Finland
NA
+∞
9.4
9
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
9.4
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.4
9.4
50
175
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
9.4
38
108
JN4BD
NOMESCO Finland
Extensive body CT
3.9
9.2
39
115
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
9.7
9.2
18
20
R52.9
ICD-10 Finland
Pain, unspecified
4.2
9.2
35
94
N06AX11
ATC
mirtazapine; oral
2.6
9.2
89
461
WX002
NOMESCO Finland
Sedation and analgesia
3.0
9.1
60
245
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
7.4
9.1
21
31
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.1
9.1
24
43
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
19.6
9.0
13
7
H65.2
ICD-10 Finland
Chronic serous otitis media
25.2
9.0
12
5
L04AX01
ATC
azathioprine; systemic
7.1
8.9
21
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.0
8.9
24
44
R06AX22
ATC
ebastine; oral
2.9
8.9
59
243
XG466
NOMESCO Finland
Sleep oxymetry
8.2
8.9
19
25
G72.9
ICD-10 Finland
Myopathy, unspecified
52.1
8.7
10
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.9
8.7
36
104
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.1
8.7
23
41
A02BC02
ATC
pantoprazole; systemic
2.4
8.6
154
1075
R51.80
ICD-10 Finland
Headache
3.1
8.6
52
202
ZXE00
NOMESCO Finland
One hour or less
2.4
8.6
105
610
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.0
8.6
23
42
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
21.0
8.6
12
6
A07AA09
ATC
vancomycin; oral
21.0
8.6
12
6
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
93.5
8.5
9
*
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
93.5
8.5
9
*
ZX112
NOMESCO Finland
Subcutaneous
7.6
8.5
19
27
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.5
8.4
41
136
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
10.0
8.4
16
17
R06AE09
ATC
levocetirizine; oral
2.9
8.4
57
238
R01AD11
ATC
triamcinolone; nasal
3.9
8.4
35
102
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
8.4
101
580
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
8.4
8
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.7
8.3
17
21
P01BA02
ATC
hydroxychloroquine; oral
4.0
8.2
33
93
ZXA10
NOMESCO Finland
Bilateral
2.8
8.2
56
235
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.8
8.1
35
105
R05
ICD-10 Finland
Cough
2.8
8.1
58
250
R06AE07
ATC
cetirizine; oral
2.3
8.1
122
773
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
6.6
8.1
20
33
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.1
8.0
48
184
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.6
8.0
37
118
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
9.0
8.0
16
19
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
7.4
8.0
18
26
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.7
7.9
22
42
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
7.9
95
538
J01.1
ICD-10 Finland
Acute frontal sinusitis
11.4
7.9
14
13
M35.7
ICD-10 Finland
Hypermobility syndrome
11.4
7.9
14
13
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
7.9
98
564
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
6.0
7.9
21
38
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
6.8
7.9
19
30
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
7.9
43
154
ZXA00
NOMESCO Finland
Right side
2.6
7.9
68
324
R13
ICD-10 Finland
Dysphagia
4.7
7.8
26
61
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.4
7.8
39
132
ZXD05
NOMESCO Finland
Urgent procedure
2.4
7.8
83
443
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.6
7.8
22
43
A02BC01
ATC
omeprazole; systemic
2.5
7.8
70
343
M79.7
ICD-10 Finland
Fibromyalgia
7.2
7.8
18
27
C07AB07
ATC
bisoprolol; oral
2.3
7.7
100
586
UKC02
NOMESCO Finland
Cystoscopy
3.4
7.7
38
127
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
12.5
7.7
13
11
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
19.2
7.7
11
6
UDM02
NOMESCO Finland
Sinoscopy
8.1
7.5
16
21
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.3
7.5
27
69
B29
ICPC
Lymph/immune mech sympt/complt other
82.7
7.5
8
*
ZX110
NOMESCO Finland
Intracutaneous
82.7
7.5
8
*
UJF32
NOMESCO Finland
Coloscopy
2.5
7.5
64
305
WW500
NOMESCO Finland
Blood transfusion
5.8
7.4
20
37
D07AA02
ATC
hydrocortisone; topical
3.1
7.3
42
157
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.4
7.3
11
7
DMB10
NOMESCO Finland
Radical maxillary antrotomy
16.4
7.3
11
7
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
7.3
32
98
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
7.0
7.3
17
26
GD1AD
NOMESCO Finland
Thorax CT examination
6.4
7.2
18
30
J01.4
ICD-10 Finland
Acute pansinusitis
31.1
7.2
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
7.2
27
72
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
9.3
7.2
14
16
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.9
7.1
47
191
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.1
7.1
40
147
SPAT1262
SPAT
Handing over of treatment supplies
2.8
7.1
47
192
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
6.7
7.1
17
27
A06AD11
ATC
lactulose; oral
3.3
7.1
36
124
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
7.1
57
261
A01AB09
ATC
miconazole; local oral
3.6
7.1
31
95
Z3229
NOMESCO Finland
Other healthcare associate professional
3.8
7.0
29
84
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.4
7.0
66
329
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.5
7.0
32
101
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
7.0
39
143
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
7.1
7.0
16
24
L04AA13
ATC
leflunomide; oral
6.5
6.9
17
28
M05BB03
ATC
alendronic acid and colecalciferol; oral
9.8
6.9
13
14
J05AB01
ATC
aciclovir; systemic
2.4
6.9
63
310
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.5
6.9
32
103
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.2
6.8
25
65
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.2
6.8
25
65
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.6
6.8
15
21
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.8
6.8
28
81
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.4
6.8
10
6
ZX114
NOMESCO Finland
Intramuscular
17.4
6.8
10
6
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
41.4
6.8
8
*
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
41.4
6.8
8
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.7
6.8
29
87
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
4.5
6.7
23
56
ZX121
NOMESCO Finland
Central venous catheter
23.3
6.7
9
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
6.7
27
77
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
6.7
33
111
N02BE01
ATC
paracetamol; systemic, rectal
2.6
6.7
193
1589
ND1AA
NOMESCO Finland
Wrist X-ray examination
4.0
6.7
26
72
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.7
6.6
21
48
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
6.5
32
107
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.2
6.5
19
39
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
7.8
6.5
14
19
A02BC03
ATC
lansoprazole; oral
2.3
6.5
70
371
A01AB04
ATC
amphotericin B; local oral
5.5
6.5
18
35
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
14.9
6.5
10
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.3
6.4
16
27
N06AA09
ATC
amitriptyline; systemic
3.2
6.4
33
115
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
6.3
35
126
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
6.3
48
212
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.7
6.3
17
32
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
6.3
26
76
DPA20
NOMESCO Finland
Trephine of frontal sinus
+∞
6.3
6
*
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
6.3
6
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
+∞
6.3
6
*
K59.0
ICD-10 Finland
Constipation
5.0
6.3
19
41
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
27.5
6.3
8
*
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.7
6.2
45
193
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
8.0
6.2
13
17
R51.81
ICD-10 Finland
Facial pain NOS
8.0
6.2
13
17
ZXD20
NOMESCO Finland
Day surgery
2.9
6.2
39
154
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.4
6.2
29
94
L28
ICPC
Limited function/disability (L)
2.9
6.2
38
147
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
7.0
6.1
14
21
R49.01
ICD-10 Finland
Functional dysphonia
6.4
6.1
15
25
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10.4
6.1
11
11
C03DA01
ATC
spironolactone; oral
3.5
6.1
27
84
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.0
6.0
35
132
S97
ICPC
Chronic ulcer skin
5.3
6.0
17
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4062490)
90
20
69.91
158.81
3.0
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
148
135
25.56
155.06
4.1
1.7
g/l
1.0
1.4
0.90
138
126
(3028192) IgG subclass 2 [Mass/volume] in Serum
86
20
65.16
149.92
2.5
1.3
g/l
2.1
3.2
1.16
69
15
(3011412) CD3 cells [#/volume] in Blood
77
20
55.29
130.12
2.2
1.7
e9/l
1.3
0.9
—
52
6
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
63
11
76.33
114.97
2.4
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
110
143
12.99
87.01
1.8
1.2
u/ml
81.9
303.7
0.77
101
135
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
55
18
38.93
86.11
2.1
1.7
e6/l
435.6
807.2
0.88
48
13
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
49
20
30.26
71.01
2.1
1.6
e6/l
929.4
804.1
—
21
9
(3023419) Bacteria identified in Sputum by Culture
47
22
26.10
64.55
3.8
3.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
168
485
8.57
63.11
4.1
1.4
g/l
1.7
2.2
4.63
142
301
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
43
22
23.42
56.74
3.6
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
41
15.39
53.76
2.2
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
39
19
24.15
52.38
3.8
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
183
661
7.67
51.62
18.5
6.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
45
13.99
50.77
2.2
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
30
16.64
47.05
2.4
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
109
267
6.48
45.99
3.3
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
220
1084
9.84
40.43
20.8
5.9
e9/l
1.9
2.0
0.24
220
968
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
31
14.29
39.32
1.8
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
139
6.75
37.02
3.8
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
53
79
8.25
35.50
3.4
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
32
23
15.82
35.44
3.7
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
89
224
5.63
35.37
2.9
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
226
1221
10.21
35.18
25.1
9.7
e9/l
4.0
3.9
0.23
221
1063
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
32
24
15.15
34.60
3.7
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
131
462
4.87
34.37
9.2
3.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
30
21
16.11
33.64
2.2
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
30
21
16.11
33.64
2.2
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
30
21
16.11
33.64
2.2
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
82
200
5.62
33.60
3.5
2.1
nmol/l
309.2
362.9
1.32
74
185
(3000494) Fungus identified in Specimen by Culture
90
239
5.33
33.42
2.5
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
48
10.03
33.24
3.0
2.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
22
15.37
32.79
1.9
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
34
31
12.54
32.70
4.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
34
31
12.54
32.70
4.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
34
31
12.54
32.70
4.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
33
29
12.97
32.47
4.4
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
27
13.45
32.27
1.8
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
33
30
12.53
31.77
4.4
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
33
30
12.53
31.77
4.4
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
13
20.32
30.35
2.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
23
14.14
30.27
2.0
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
91
271
4.72
28.89
3.5
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
14
18.00
27.50
2.6
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
23
14
18.00
27.50
2.6
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
14
18.00
27.50
2.6
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
14
18.00
27.50
2.6
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
71
180
5.12
27.34
2.4
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
44
72
7.21
26.82
4.9
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
130
533
4.01
26.19
14.8
7.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
37
51
8.35
26.19
4.1
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
92
303
4.23
25.14
1.9
1.4
titre
475.6
451.3
0.08
18
71
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
29
7
46.65
24.20
1.1
1.0
%
100.9
98.6
—
29
7
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
29
7
46.65
24.20
1.1
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
42
73
6.72
24.10
4.6
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
67
183
4.64
23.27
2.5
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
24
11.47
23.04
2.0
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
87
292
4.04
22.90
3.8
2.2
umol/l
11.9
13.9
1.61
82
273
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
169
880
3.86
22.82
4.6
2.4
nmol/l
81.9
77.1
1.35
162
789
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
21
0
+∞
22.21
1.6
0.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
61
163
4.63
21.67
7.8
4.5
%
0.6
0.6
0.06
28
41
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
19
12.60
21.64
1.4
1.3
u/ml
0.4
0.1
—
13
7
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
77
247
4.07
21.45
3.7
2.3
%
20.3
23.5
1.02
71
214
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
185
1071
3.83
20.18
9.8
6.3
umol/l
8.6
10.7
3.76
180
1019
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
19
0
+∞
20.07
1.8
0.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
15
13.63
19.65
2.2
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
170
944
3.52
19.57
16.8
7.2
mmol/l
1.2
1.2
0.48
147
810
(3021440) Promyelocytes/100 leukocytes in Blood
60
171
4.31
19.48
8.9
4.8
%
0.1
0.1
0.04
33
53
(3017181) Myelocytes/100 leukocytes in Blood
62
183
4.18
19.19
8.9
4.7
%
0.8
0.9
0.17
33
61
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
40
7.76
19.07
6.6
6.9
iu/ml
121.8
519.9
—
5
9
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
158
862
3.28
18.27
17.1
6.6
mmol/l
1.2
1.2
1.23
152
793
(3004588) Protein electrophoresis panel - Serum or Plasma
46
112
4.81
18.16
2.3
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
97
5.01
17.64
2.5
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
103
450
3.20
17.28
3.9
3.0
ng/l
709.7
661.4
0.11
89
371
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
36
7.61
16.86
1.2
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
42
101
4.80
16.78
2.0
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
55
164
4.02
16.64
9.2
4.9
%
0.0
0.0
0.80
28
46
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
40
7.14
16.54
2.0
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
226
1597
5.49
16.43
21.6
7.3
u/l
78.0
78.0
0.01
221
1496
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
22
9
26.64
16.31
2.5
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
56
5.95
15.85
1.6
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
18
19
10.13
15.40
3.1
3.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
31
63
5.48
14.96
1.9
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
20
8
27.00
14.94
2.8
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
20
8
27.00
14.94
2.8
2.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
20
8
27.00
14.94
2.8
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
64
5.39
14.70
1.6
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
129
696
2.77
14.04
8.8
6.5
inr
1.0
1.1
1.63
39
220
(44790049)
17
19
9.53
13.93
1.2
1.7
—
—
—
0
0
(44806118)
17
19
9.53
13.93
1.2
1.7
—
—
—
0
0
(44790047)
17
19
9.53
13.93
1.2
1.7
—
—
—
0
0
(44790048)
17
19
9.53
13.93
1.2
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
60
5.34
13.70
1.9
1.5
ug/g
297.6
274.1
0.24
17
33
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
17
9.99
13.58
4.8
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
114
4.11
13.52
10.0
4.6
mmol/l
2.4
1.6
0.73
36
82
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
27
53
5.59
13.49
1.3
1.3
u/ml
3.3
1.1
—
5
5
(3009343) pH of Capillary blood
42
120
4.01
13.34
10.2
4.4
ph
7.4
7.4
—
5
14
(46235355) HIV 1 and 2 tests - Meaningful Use set
97
464
2.79
13.17
2.3
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
46
144
3.69
12.81
4.8
2.6
e9/l
76.3
71.6
0.32
40
111
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
11
12.41
12.73
1.8
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
103
518
2.69
12.57
12.2
4.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
71
296
2.96
12.37
2.2
2.5
ug/g
212.2
119.1
0.59
53
233
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
24
46
5.67
12.28
1.1
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
28
62
4.96
12.23
1.8
1.9
—
256.0
—
0
5
(40768797) Stomach Pathology biopsy report
67
273
2.99
12.14
1.3
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
12
11.38
12.05
2.6
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
95
468
2.67
11.98
2.9
2.0
mg/l
1.4
1.1
0.42
75
357
(3021589) Normoblasts [#/volume] in Blood
154
958
2.59
11.88
25.3
8.5
e9/l
0.0
0.0
1.02
140
779
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
128
731
2.55
11.84
2.6
1.9
pmol/l
96.2
98.3
0.16
69
369
(3001122) Ferritin [Mass/volume] in Serum or Plasma
151
933
2.57
11.78
4.8
2.7
ug/l
126.3
91.0
1.15
146
862
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
15
9.83
11.76
1.9
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
116
636
2.54
11.65
3.9
2.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
83
4.28
11.51
1.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
120
672
2.52
11.48
5.3
3.3
ng/l
25.6
26.9
0.05
78
421
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
62
4.76
11.29
2.8
1.2
g/l
2.7
3.2
1.29
19
53
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
42
5.65
11.28
6.3
3.8
e9/l
3.5
4.4
0.82
22
42
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
32
6.35
11.03
2.3
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
43
5.52
11.00
9.1
4.3
%
54.2
55.7
0.16
22
43
(3018418) pH of Serum or Plasma
108
587
2.48
10.89
8.6
3.7
ph
7.4
7.4
0.40
25
107
(3022145) Colonoscopy Study observation
60
244
2.92
10.81
1.5
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
69
4.45
10.74
2.7
1.2
g/l
7.2
7.6
0.58
19
56
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
69
4.45
10.74
2.7
1.2
g/l
4.2
3.9
0.16
19
53
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
69
4.45
10.74
2.7
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
17
8.67
10.72
1.1
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
199
1443
2.89
10.61
10.0
4.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
12
10.46
10.52
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
89
3.98
10.48
12.4
4.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
130
3.47
10.46
1.8
1.2
—
—
—
0
0
(4010399)
43
147
3.33
10.38
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
121
704
2.40
10.36
8.6
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
71
4.32
10.35
5.6
4.4
g/l
0.4
0.5
0.10
14
27
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
15
9.09
10.32
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
158
1040
2.42
10.13
8.3
4.7
estimate
0.0
0.0
0.50
34
210
(3015736) pH of Urine
134
822
2.36
10.09
5.6
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
159
1051
2.42
10.07
6.5
3.4
estimate
0.0
0.0
0.00
34
199
(3052851) Hemolysis interference index of Serum or Plasma
24
55
4.72
10.04
3.7
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
39
5.49
10.01
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
39
5.49
10.01
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
47
175
3.08
9.84
12.7
11.5
mmol/l
1.9
1.4
0.20
40
141
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
26
66
4.28
9.59
2.7
2.2
g/l
1.6
1.5
0.06
20
58
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
8
18.43
9.51
2.6
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
32
96
3.68
9.40
6.6
10.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
65
296
2.62
9.32
2.1
1.7
nmol/l
1344.6
1170.6
0.77
55
213
(3035350) Ketones [Presence] in Urine by Test strip
155
1036
2.31
9.24
6.5
3.3
estimate
0.0
0.0
0.00
33
206
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
55
4.51
9.13
1.4
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
31
5.81
9.10
1.1
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
51
4.63
9.07
1.3
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
80
407
2.42
9.04
6.1
2.4
e6/l
4.6
5.9
0.53
75
360
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
7
19.50
9.03
2.7
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
15
8.35
8.93
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
49
197
2.85
8.91
2.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
62
282
2.60
8.87
2.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
44
4.86
8.76
1.6
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
465
2.34
8.75
6.2
3.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
10
10.38
8.70
1.4
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
10
10.38
8.70
1.3
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
8
17.04
8.65
2.7
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
8
17.04
8.65
2.0
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
17
33
5.46
8.53
1.6
1.5
—
—
—
0
0
(3020891) Body temperature
24
63
4.11
8.46
5.9
5.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
26
6.07
8.43
1.0
1.4
nmol/l
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
89
3.56
8.22
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
87
476
2.27
8.20
3.4
2.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
10
11
9.43
8.14
1.6
1.4
mmol/l
1.8
2.0
—
10
11
(3018095) Leukocytes [#/volume] in Urine
117
725
2.16
8.06
8.8
3.6
e6/l
13.9
55.6
2.91
89
489
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
14
8.17
8.05
2.5
1.1
—
—
—
0
0
(4034850)
24
66
3.92
7.95
19.0
9.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
15
28
5.64
7.83
1.3
1.3
pmol/l
420.7
356.0
—
10
22
(3017732) Neutrophils [#/volume] in Blood
39
149
2.92
7.74
3.2
2.0
e9/l
4.2
4.1
0.05
25
121
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
45
186
2.73
7.72
6.0
3.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
25
5.87
7.63
1.7
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
95
552
2.17
7.63
8.1
3.0
e6/l
0.4
0.4
0.12
81
402
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
74
391
2.27
7.49
2.1
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
26
5.65
7.33
1.4
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
241
2141
4.91
7.26
49.8
12.1
mg/l
16.9
21.1
1.94
224
1645
(3045142) Bone marrow Pathology biopsy report
13
23
5.91
7.14
1.8
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
27
5.43
7.05
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
27
5.43
7.05
4.1
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
77
423
2.19
7.04
2.1
1.5
nmol/l
24.2
22.0
0.54
67
357
(3045424) Erythrocytes [Presence] in Urine
16
35
4.82
7.04
2.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
15
31
5.08
7.02
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
83
3.38
6.94
2.3
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
99
602
2.07
6.93
8.0
3.0
e6/l
12.3
58.4
2.34
84
451
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
17
6.72
6.83
1.1
1.1
u/ml
2.6
3.2
—
5
6
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
38
153
2.75
6.83
1.6
1.3
—
37.5
—
0
12
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
6
17.27
6.80
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
28
5.24
6.79
2.5
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
37
148
2.76
6.73
31.2
9.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
92
550
2.07
6.70
8.1
2.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
25
5.43
6.56
1.5
1.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
25
5.43
6.56
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
15
6.90
6.36
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
84
494
2.06
6.34
3.1
2.7
umol/l
4179.2
6320.3
0.20
77
430
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
88
3.18
6.33
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
72
3.42
6.32
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
26
5.22
6.29
1.7
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
43
4.17
6.28
1.4
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
175
2.53
6.09
1.8
1.2
iu/ml
33.4
153.9
3.48
19
68
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
64
344
2.16
6.08
3.8
3.4
ng/l
159.7
220.0
0.18
32
233
(3019225) pH of Specimen
39
169
2.55
6.05
8.4
4.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
16
6.47
6.00
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
16
6.47
6.00
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
6
15.49
5.95
1.3
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
6
15.49
5.95
1.3
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
6
15.49
5.95
1.3
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
6
15.49
5.95
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
20
5.71
5.86
1.3
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
69
388
2.08
5.81
1.5
1.3
iu/ml
13.4
31.7
2.46
20
131
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
16
41
4.10
5.81
1.8
1.1
iu/ml
68.6
25.4
—
7
7
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
41
4.10
5.81
2.1
2.3
g/l
123.1
133.6
—
8
27
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
28
4.84
5.80
1.2
1.0
u/ml
8.3
3.4
—
7
5
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
68
381
2.08
5.78
1.4
1.3
u/ml
5.2
8.1
0.30
19
157
(3029937) Albumin [Presence] in Urine by Test strip
89
554
1.94
5.61
7.6
3.4
estimate
0.0
0.0
0.50
34
210
(4035726)
40
183
2.41
5.53
1.9
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
39
179
2.40
5.35
2.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
44
3.82
5.29
1.9
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
45
3.73
5.13
1.4
1.6
u/ml
110.7
111.3
—
6
7
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
36
4.06
5.06
1.6
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
83
2.95
5.03
17.0
16.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
32
4.23
4.96
1.6
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
62
3.24
4.90
1.4
1.5
iu/ml
0.0
0.1
—
5
11
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
24
4.75
4.83
1.3
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
10
9.28
4.82
1.8
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
10
9.28
4.82
1.8
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
10
9.28
4.82
1.8
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
10
9.28
4.82
1.8
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
7
11.75
4.82
4.4
2.6
umol/l
3.7
6.8
—
8
7
(3026008) Bacteria identified in Urine by Culture
91
597
1.83
4.74
6.4
2.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
29
4.30
4.68
1.4
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
29
4.30
4.68
1.2
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
5
14.34
4.60
1.9
3.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
39
3.74
4.55
1.2
1.2
u/ml
0.9
2.9
—
7
18
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
187
1530
1.89
4.53
5.2
3.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
226
1983
2.51
4.48
31.8
11.0
ml/min/173m2
87.7
86.3
0.42
210
1598
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
50
3.35
4.42
1.3
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
131
971
1.74
4.40
6.6
4.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
40
3.65
4.40
1.6
3.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
12
7.73
4.39
1.4
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
22
4.69
4.34
1.1
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
6
11.95
4.30
1.6
1.2
u/l
7.6
12.0
—
7
6
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
386
1.89
4.29
1.9
1.7
pmol/l
486.9
459.3
0.37
56
321
(3000475) Leukocytes [#/volume] in Synovial fluid
14
41
3.56
4.25
2.2
1.4
e6/l
38401.6
23473.6
—
9
28
(40761511) CBC panel - Blood by Automated count
242
2245
3.77
4.14
34.8
11.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
118
860
1.71
4.14
2.5
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
76
492
1.78
4.04
2.0
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
23
94
2.59
4.02
10.2
12.8
mmol/l
26.1
24.9
0.95
23
88
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
33
3.77
3.97
1.2
1.1
u/ml
0.6
0.7
—
6
13
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
24
4.30
3.92
1.3
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
24
4.30
3.92
1.3
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
24
4.30
3.92
1.3
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
24
4.30
3.92
1.3
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
24
4.30
3.92
1.3
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
24
4.30
3.92
1.3
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
8
11
7.47
3.89
1.6
1.4
u/l
477.0
285.4
—
8
11
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
179
1485
1.73
3.68
5.3
3.2
u/l
64.7
42.7
1.31
173
1405
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
20
80
2.63
3.65
3.4
4.6
%
50.1
50.5
0.02
20
80
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
195
1664
1.79
3.55
6.5
4.0
pmol/l
14.7
14.6
0.22
184
1526
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
17
5.45
3.54
1.4
1.3
—
—
—
0
0
(3013512) EKG study
81
552
1.69
3.53
4.9
3.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
36
3.45
3.52
3.7
2.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
10
7.16
3.38
1.3
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
10
7.16
3.38
1.3
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
10
7.16
3.38
3.1
3.0
—
—
—
0
0
(4027681)
8
14
5.86
3.37
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
14
5.86
3.37
1.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
208
1.98
3.36
3.7
2.5
u/l
49.6
27.2
0.91
33
171
(3015377) Calcium [Moles/volume] in Serum or Plasma
96
691
1.63
3.36
3.6
3.1
mmol/l
2.3
2.4
1.07
81
610
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
326
1.79
3.29
6.5
2.7
e6/l
0.5
0.8
0.84
32
170
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
7
8.74
3.28
3.8
3.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
7
8.74
3.28
1.5
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
7
8.74
3.28
1.0
1.0
miu/ml
2917.3
1697.6
—
6
7
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
11
6.51
3.20
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
313
1.79
3.19
6.6
2.9
e6/l
2.9
2.8
0.06
30
157
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
20
4.63
3.14
1.6
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
108
811
1.59
3.13
7.1
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
30
155
2.06
3.11
8.2
3.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
16
5.13
3.07
1.0
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
44
261
1.83
3.07
1.7
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
12
5.97
3.04
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
40
3.10
3.01
1.4
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
5
10.17
2.99
1.2
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
35
3.24
2.97
57.8
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
30
3.43
2.94
2.4
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
30
3.43
2.94
2.2
5.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
13
5.50
2.89
1.4
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
77
542
1.61
2.88
1.4
1.3
u/ml
0.6
1.4
1.40
21
157
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
9
6.80
2.88
1.3
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
9
6.80
2.88
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
9
6.80
2.88
1.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
66
448
1.64
2.86
6.6
3.4
kg/l
1.0
1.0
—
6
59
(3026389) Candida sp identified in Specimen by Organism specific culture
8
18
4.55
2.82
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
219
1977
1.89
2.78
7.4
4.7
mu/l
1.8
2.5
0.59
214
1832
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
48
2.80
2.76
1.6
1.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
6
8.47
2.76
3.0
4.5
%
252.4
136.0
—
5
6
(40765096) Chromosome analysis panel by Banding
5
6
8.47
2.76
1.4
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
6
8.47
2.76
2.6
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
10
6.12
2.71
6.5
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
10
6.12
2.71
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
81
585
1.57
2.70
3.9
3.2
mmol/l
6.8
7.6
0.78
75
498
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
19
4.31
2.70
6.0
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
24
3.85
2.70
3.8
1.6
pg
32.3
33.4
—
9
24
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
24
3.85
2.70
1.1
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
94
2.23
2.63
1.8
2.4
u/l
388.4
3054.2
—
6
35
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
15
4.77
2.61
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
235
1.78
2.58
5.0
4.1
%
33.1
33.1
0.00
34
156
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
7
7.26
2.56
1.2
1.1
%
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
39
2.90
2.51
4.5
2.9
kpa
9.0
9.0
0.02
11
39
(3013290) Carbon dioxide [Partial pressure] in Blood
11
39
2.90
2.51
4.6
2.9
kpa
4.7
5.0
0.46
11
39
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
20
96
2.18
2.51
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
26
3.55
2.50
1.6
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
26
3.55
2.50
2.1
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
51
2.63
2.48
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
27
3.42
2.41
1.7
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
12
5.09
2.41
1.5
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
12
5.09
2.41
1.8
2.0
—
—
—
0
0
(4024509)
6
12
5.09
2.41
1.8
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
8
6.35
2.38
2.6
3.6
%
37.5
47.3
—
5
8
(3017704) Immunofixation for Urine
5
8
6.35
2.38
1.0
2.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
13
4.70
2.28
2.2
2.2
umol/l
9.1
10.5
—
6
13
(44813793)
7
18
3.97
2.27
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
36
2.85
2.23
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
298
1.62
2.13
2.0
2.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
10
5.08
2.08
1.2
5.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
10
5.08
2.08
1.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
20
3.57
2.07
1.1
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
51
2.42
1.98
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
27
3.03
1.95
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
29
175
1.74
1.93
8.7
3.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
72
2.15
1.90
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
68
509
1.46
1.85
3.9
3.2
mg/l
71.4
194.2
0.43
43
314
(40768441) Liver Pathology biopsy report
6
17
3.59
1.85
1.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
17
3.59
1.85
1.5
1.7
g/l
0.8
1.1
—
6
17
(3051611) Lipemic interference index of Serum or Plasma
6
17
3.59
1.85
6.5
2.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
73
2.12
1.85
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
78
600
1.44
1.84
5.5
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
76
582
1.44
1.83
1.7
1.7
mmol/l
1.3
1.4
0.61
69
493
(3012441) Differential panel - Pleural fluid
5
12
4.23
1.83
1.6
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
29
2.82
1.80
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
74
2.09
1.79
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
252
0.49
1.76
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
204
1.65
1.76
3.3
4.1
ug/l
4.1
28.6
0.62
24
167
(3028271) Lactate [Moles/volume] in Capillary blood
8
30
2.72
1.74
2.5
2.1
mmol/l
1.9
1.6
—
8
30
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
24
2.97
1.73
1.3
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
24
2.97
1.73
1.0
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
49
350
1.50
1.67
3.7
2.4
mmol/l
2.4
2.4
0.31
40
308
(4281824)
6
19
3.21
1.67
1.7
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
14
3.62
1.62
2.0
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
14
3.62
1.62
1.4
1.1
g/l
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
185
1.64
1.60
1.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
21
2.90
1.51
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
125
1.74
1.49
3.8
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
45
325
1.47
1.46
2.2
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
59
2.09
1.46
2.5
1.6
iu/l
2.7
5.7
—
5
22
(3000093) Morphology [Interpretation] in Blood Narrative
5
16
3.17
1.44
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
16
3.17
1.44
3.2
3.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
166
1.63
1.44
3.2
2.6
ml/min/173m2
65.5
71.0
—
10
72
(1761868) Lipid panel - Serum or Plasma
68
847
0.73
1.41
2.6
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
40
2.30
1.41
1.2
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
69
543
1.37
1.40
4.6
3.9
mg/mmol
20.8
9.3
0.38
47
331
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
41
2.24
1.38
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
23
2.65
1.37
4.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
75
1.92
1.37
2.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
9
44
2.08
1.28
2.3
2.0
nmol/l
0.9
0.8
—
9
36
(3014051) Protein [Presence] in Urine by Test strip
9
44
2.08
1.28
3.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
171
0.51
1.23
1.6
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
235
0.57
1.22
1.8
1.6
—
—
—
0
0
(4306422)
8
39
2.09
1.16
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
20
2.53
1.15
1.0
3.4
%
103.0
104.3
—
5
20
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
30
2.37
1.13
1.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
38
280
1.42
1.13
1.3
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
32
2.22
1.09
2.1
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
33
2.15
1.06
2.0
2.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
245
0.63
0.99
2.3
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
27
2.25
0.94
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
42
1.93
0.89
3.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
17
112
1.56
0.87
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
267
1.36
0.87
1.7
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
47
1.73
0.81
1.5
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
33
1.84
0.79
104.0
2.4
%
70.0
64.1
—
6
33
(1617658) Protocol used for examination of sentinel lymph nodes
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
212
2025
1.32
0.79
5.0
4.2
mmol/l
5.9
5.8
0.62
201
1885
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
76
1.61
0.73
1.6
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
152
1407
1.21
0.72
4.8
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
200
1906
1.25
0.69
6.7
5.1
mmol/mol
39.0
38.9
0.04
192
1788
(3023511) Choriogonadotropin [Units/volume] in Urine
9
59
1.54
0.69
1.4
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
121
1.43
0.64
1.1
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
29
1.74
0.64
2.6
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
133
1.38
0.57
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
76
1.47
0.49
1.9
2.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
46
1.54
0.48
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
19
239
0.78
0.43
15.2
5.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
87
1.40
0.43
1.6
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(4268621)
5
36
1.40
0.38
2.8
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
206
2003
1.16
0.37
4.1
3.8
mmol/l
1.4
1.3
1.89
197
1869
(3016879) Cocaine [Presence] in Urine
12
90
1.35
0.36
1.8
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
183
1.22
0.33
2.7
2.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
131
0.75
0.31
2.8
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
93
1.31
0.30
2.9
3.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
148
1.23
0.30
2.2
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
38
338
1.15
0.28
3.2
4.3
ug/l
1.6
1.7
0.31
38
305
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
95
1.28
0.27
2.7
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
86
1.29
0.26
1.7
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
75
0.66
0.26
1.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
50
457
1.12
0.25
1.7
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
98
1.24
0.21
1.8
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
98
1.24
0.21
1.8
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
98
1.24
0.21
1.8
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
43
1.17
0.21
1.8
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
52
1.16
0.19
2.2
3.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
61
1.15
0.17
1.1
2.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
69
0.72
0.17
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
69
0.72
0.17
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
69
0.72
0.17
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
69
0.72
0.17
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
70
1.15
0.16
1.9
3.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
79
0.75
0.15
1.2
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
150
1.14
0.15
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
88
0.79
0.15
1.1
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
198
2009
0.93
0.14
38.2
13.2
%
40.0
40.3
0.32
153
1570
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
139
0.86
0.14
2.3
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
212
2093
1.09
0.14
4.6
4.2
mmol/l
4.8
4.8
0.09
205
1963
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
211
2085
1.08
0.13
4.7
4.2
mmol/l
1.6
1.5
0.57
204
1950
(3003694) ABO and Rh group [Type] in Blood
66
634
1.06
0.11
1.7
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
97
1.14
0.09
1.9
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
117
1.12
0.08
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
213
2121
1.03
0.02
5.1
4.7
mmol/l
2.8
2.9
0.60
203
1985
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
274
1.02
0.00
3.6
4.1
%
22.1
21.5
0.07
15
118
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_DEF_IGG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_DEF_IGG | 2.525 [1.85, 3.45] | < 0.001 |
| Birth year | 1.0 [0.99, 1.01] | 0.938 |
During the follow-up period (1.1.1998 — 31.12.2019), 72 out of 613 females with D3_DEF_IGG died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have D3_DEF_IGG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.284% | No data |
| 5 | 1.813% | No data |
| 10 | 4.498% | No data |
| 15 | 8.646% | No data |
| 20 | 14.401% | No data |
Relationships between endpoints
↥Index endpoint: D3_DEF_IGG – Selective deficiency of immunoglobulin G [IgG] subclasses
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data